276 related articles for article (PubMed ID: 10531103)
1. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.
de Abajo FJ; Rodríguez LA; Montero D
BMJ; 1999 Oct; 319(7217):1106-9. PubMed ID: 10531103
[TBL] [Abstract][Full Text] [Related]
2. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
Tata LJ; Fortun PJ; Hubbard RB; Smeeth L; Hawkey CJ; Smith CJ; Whitaker HJ; Farrington CP; Card TR; West J
Aliment Pharmacol Ther; 2005 Aug; 22(3):175-81. PubMed ID: 16091054
[TBL] [Abstract][Full Text] [Related]
3. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.
Vidal X; Ibáñez L; Vendrell L; Conforti A; Laporte JR;
Drug Saf; 2008; 31(2):159-68. PubMed ID: 18217791
[TBL] [Abstract][Full Text] [Related]
4. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
de Abajo FJ; García-Rodríguez LA
Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
[TBL] [Abstract][Full Text] [Related]
5. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.
Dalton SO; Johansen C; Mellemkjaer L; Nørgård B; Sørensen HT; Olsen JH
Arch Intern Med; 2003 Jan; 163(1):59-64. PubMed ID: 12523917
[TBL] [Abstract][Full Text] [Related]
6. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.
Anglin R; Yuan Y; Moayyedi P; Tse F; Armstrong D; Leontiadis GI
Am J Gastroenterol; 2014 Jun; 109(6):811-9. PubMed ID: 24777151
[TBL] [Abstract][Full Text] [Related]
7. Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity.
Lewis JD; Strom BL; Localio AR; Metz DC; Farrar JT; Weinrieb RM; Nessel L; Brensinger C; Kimmel SE
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):328-35. PubMed ID: 18188866
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
[TBL] [Abstract][Full Text] [Related]
9. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
Hippisley-Cox J; Coupland C; Logan R
BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
[TBL] [Abstract][Full Text] [Related]
10. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
Andrade C; Sandarsh S; Chethan KB; Nagesh KS
J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study.
van Walraven C; Mamdani MM; Wells PS; Williams JI
BMJ; 2001 Sep; 323(7314):655-8. PubMed ID: 11566827
[TBL] [Abstract][Full Text] [Related]
12. Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding.
Wang YP; Chen YT; Tsai CF; Li SY; Luo JC; Wang SJ; Tang CH; Liu CJ; Lin HC; Lee FY; Chang FY; Lu CL
Am J Psychiatry; 2014 Jan; 171(1):54-61. PubMed ID: 24030313
[TBL] [Abstract][Full Text] [Related]
13. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis.
Wessinger S; Kaplan M; Choi L; Williams M; Lau C; Sharp L; Crowell MD; Keshavarzian A; Jones MP
Aliment Pharmacol Ther; 2006 Apr; 23(7):937-44. PubMed ID: 16573796
[TBL] [Abstract][Full Text] [Related]
14. [Is the use of selective serotonin reuptake inhibitors associated with an increased risk of bleeding?].
Dall M; Hallas J
Ugeskr Laeger; 2006 Jun; 168(23):2232-6. PubMed ID: 16768974
[TBL] [Abstract][Full Text] [Related]
15. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
[TBL] [Abstract][Full Text] [Related]
16. A model to predict the risk of aspirin/non-steroidal anti-inflammatory drugs-related upper gastrointestinal bleeding for the individual patient.
Petersen J; Møller Hansen J; de Muckadell OBS; Dall M; Hallas J
Basic Clin Pharmacol Toxicol; 2020 May; 126(5):437-443. PubMed ID: 31765070
[TBL] [Abstract][Full Text] [Related]
17. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding.
Dall M; Schaffalitzky de Muckadell OB; Lassen AT; Hansen JM; Hallas J
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1314-21. PubMed ID: 19716436
[TBL] [Abstract][Full Text] [Related]
18. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.
Ahsberg K; Höglund P; Kim WH; von Holstein CS
Scand J Gastroenterol; 2010 Dec; 45(12):1404-15. PubMed ID: 20695720
[TBL] [Abstract][Full Text] [Related]
19. Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature.
Mort JR; Aparasu RR; Baer RK
Pharmacotherapy; 2006 Sep; 26(9):1307-13. PubMed ID: 16945053
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
Lin CC; Hu HY; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
Aliment Pharmacol Ther; 2013 Nov; 38(9):1119-28. PubMed ID: 24099473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
